Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children [8]

M. J. Mphahlele^*, R. J. Burnett, T. Kyaw, H. S. Schoeman, S. Aspinall

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	280-281
Number of pages	2
Journal	South African Medical Journal
Volume	94
Issue number	4
Publication status	Published - Apr 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d37471b5002a4774a45807fcea39eb34,

title = "Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children [8]",

author = "Mphahlele, {M. J.} and Burnett, {R. J.} and T. Kyaw and Schoeman, {H. S.} and S. Aspinall",

year = "2004",

month = apr,

language = "English",

volume = "94",

pages = "280--281",

journal = "South African Medical Journal",

issn = "0256-9574",

publisher = "South African Medical Association",

number = "4",

}

TY - JOUR

T1 - Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children [8]

AU - Mphahlele, M. J.

AU - Burnett, R. J.

AU - Kyaw, T.

AU - Schoeman, H. S.

AU - Aspinall, S.

PY - 2004/4

Y1 - 2004/4

UR - http://www.scopus.com/inward/record.url?scp=2342558031&partnerID=8YFLogxK

M3 - Letter

C2 - 15150941

AN - SCOPUS:2342558031

SN - 0256-9574

VL - 94

SP - 280

EP - 281

JO - South African Medical Journal

JF - South African Medical Journal

IS - 4

ER -